Details for New Drug Application (NDA): 021045
✉ Email this page to a colleague
NDA 021045 describes PLAN B, which is a drug marketed by Fdn Consumer and is included in two NDAs. Additional details are available on the PLAN B profile page.
The generic ingredient in PLAN B is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
The generic ingredient in PLAN B is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 021045
| Tradename: | PLAN B |
| Applicant: | Fdn Consumer |
| Ingredient: | levonorgestrel |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021045
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 28, 1999 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Aug 24, 2006 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
